2022
SDI
Affirmative
**Human Germline Genetic Engineering** Affirmative › Advantage 1 – Extension › Eugenics/discrimination
Neal Baer 2020 Quals: Neal Baer is an award-winning showrunner, television writer/producer, physician, author, and a public health advocate and expert."Commentary: Code Dread?" Perspectives in Biology and Medicine 63, no. 1: 14-27. . /nfs
Many scientists contend that the driving question CRISPR poses is whether it fulfills an unmet medical need and can be made clinically safe. Garland-Thomson, along with many of our other contributors, cautions that we must look further to “what the existence of CRISPR technology suggests about the limits of being human.” Garland-Thomson worries that GGE approaches a “new eugenics.” Using germline editing to enhance or improve future persons, she says, may lead to “morally unacceptable consequences, ranging from producing medical harm to abrogating consent, intensifying genetic discrimination, increasing social inequality, promoting conditional parental acceptance, turning people into products, fostering a commercial medical industrial complex, and encouraging rogue scientific and medical practice.”
2022
SDI
Affirmative
**Human Germline Genetic Engineering** Affirmative › Advantage 1 – Extension › Eugenics/discrimination
Neal Baer 2020 Quals: Neal Baer is an award-winning showrunner, television writer/producer, physician, author, and a public health advocate and expert."Commentary: Code Dread?" Perspectives in Biology and Medicine 63, no. 1: 14-27. . /nfs
Doxzen and Halpern review a number of potential outcomes using GGE. They reflect on public access to medically necessary treatments and whether enhancements for one’s prospective children should ever be allowed, and they raise deep concerns about eugenics that can be conflated with our quest to improve our health and that of our future children. As national and international scientific bodies meet to develop guidelines and regulations for using GGE, Doxzen and Halpern argue that a human rights-based approach, rather than a utilitarian one, ought to “ensure that this socially disruptive technology minimizes further marginalization of people with disabilities and does not create a new form of social injustice.”
2022
SDI
Affirmative
**Human Germline Genetic Engineering** Affirmative › Advantage 1 – Extension › Eugenics/discrimination
WESLEY W. CHEN June 30 2019 HUMAN GERMLINE GENE EDITING: ENGINEERING AN UNSTOPPABLE TRAIN https://mylaw2.usc.edu/why/students/orgs/ilj/assets/docs/28-2-Chen.pdf
Eugenics is the idea of systematically applying genetic selection in humans.107 Negative eugenics teaches “breeding out” negative or unwanted characteristics (e.g. the Huntington’s Disease mutation); positive eugenics promotes desirable genetic traits (e.g. inheritable resistance to Malaria).108 While proponents for eugenics might argue that it would only be used as a positive tool for fixing some of society’s greatest problems (e.g. inheritable disorders), critics of eugenics would argue that the application of eugenics is not governed by such a bright-line rule. The controversy surrounding eugenics involves the ambiguity regarding what defines a negative or positive characteristic. There are some clear candidates for negative eugenics, such as a Tay-Sachs Disease—a fatal heritable disorder that results in severe mental retardation and death by the age of eight-years-old.109 But what about the genetic profile for Down Syndrome patients? Individuals with Down Syndrome experience mental retardation, but can live functional adult lives. Or what about the gene for lactose intolerance? When deciding what sort of genetic conditions deserve eugenic treatment, one must face the difficult, if not impossible task of making value judgments on each disorder.110 Depending on the subjective view for each person, what may be considered an unacceptable characteristic to one individual may be acceptable to another. Therefore, genetic conditions are less likely to fall neatly into rigid categories and more likely to rest in a spectrum ranging from clearly unacceptable disorders to controversial attributes. As one moves along the spectrum away from unanimously dreadful diseases, the room for disagreement increases. When such ambiguity exists, there is a greater risk that eugenics may be discriminatory. On one hand, eugenic champions might argue that it is unethical to deprive a mother an opportunity to use gene-editing technology to ensure a healthy child, and that society has a duty to produce healthier offspring.111 Negative eugenics could be limited to only clear and obvious cases (e.g., eliminating fatal genetic diseases); positive eugenics could enhance the human race through safe gene editing practices (e.g. increasing resistance to diseases). On the other hand, critics might argue that eugenics sits on a slippery slope and if we allow the possibility of “breeding out” negative characteristics, we will eventually find ourselves back in the 1940s alongside the atrocities of the Holocaust. Critics could also point out that even if society does not descend to such depths, the very concept of eugenics is discriminatory because it suggests that some lives are not worth living.112 If certain racial profiles become associated with diseases, eugenics risks stigmatizing such races.113 Furthermore, across and within different societies the economic availability of eugenic technology may greatly exacerbate inequality. For example, if the genes for high intelligence are identified and eugenic technology was only available at a high cost, already wealthy families would have a better opportunity to produce genetic “advantages” for their progeny. The ramifications of accelerating social, economic, and political stratification would be difficult to reverse.114 For such reasons, the risk of abuse has been deemed intolerable and eugenics has been mostly rejected in the past several decades.115 On the other hand, one can argue that there is a significant difference between preventing the birth of persons with certain genetic conditions and killing of persons bearing a specific trait. Especially considering the benefits that would come with eliminating unambiguously harmful genetic traits (e.g. Tay-Sachs disease116), the benefits of eugenics may outweigh the risks. Even if one was to accept that eugenics bears a substantial risk of propagating social inequality, is the risk enough to deny the benefits of eugenics to society? Benefits may come at a price. Regardless of where one stands on the eugenics debate, recent technological advances in gene editing have pumped new life into the eugenics debate. Whereas the historic versions of eugenics revolved around controlling reproductive partners—either by bringing persons together, keeping them apart, sterilization, or gamete selection (as with artificial insemination by donor)117—gene editing refines reproductive strategies by manipulating the very genetic material in any one individual.118
2022
SDI
Affirmative
**Human Germline Genetic Engineering** Affirmative › Advantage 1 – Extension › Eugenics/discrimination
Theodore Friedmann, 7-4-2019, Professor at School of Medicine, University of California San Diego, "Genetic therapies, human genetic enhancement, and … eugenics?", Nature, https://www.nature.com/articles/s41434-019-0088-1, 6-25-2022, //ms
In the blazingly rapid period of only a few decades, these tools have already progressed from curiosities of somatic cell genetics in the laboratory to early-stage clinical application in individual human patients. Genome editing studies have reached this clinical stage for applications toward preventing and correcting genetic and even infectious diseases, including HIV AIDS [], forms of leukemia [], mucopolysaccharidoses I () and II (), sickle cell disease [], and others. Such genetic manipulation has been extended to genome editing studies in the human embryo identified to be at risk for a potentially dangerous or lethal disease. Proof of that concept has been provided for CRISPR-Cas9 genome editing correction in a preimplantation human embryo of a mutation responsible for the potentially lethal disease hypertrophic cardiomyopathy []. With unsettling speed, the door has now clearly been cracked even further open for human embryonic genetic modification by a recent announcement from China of purported HIV prevention in a subsequent generation by genome editing knockout of the CCR5 HIV co-receptor followed by birth of potentially HIV-resistant human infants []. As reported, the manipulation was widely regarded to be scientifically premature, technically flawed, and ethically indefensible, but the embryo genetic modification genie is probably already out of the bottle. The technical and ethical hazards of such applications have been discussed and will continue to be of major concern, even in the case of disease prevention and treatment. From therapy to genetic enhancement When aimed at aberrant functions causing disease, genetic manipulations such as “traditional” gene therapy and, more recently, genome editing, constitute legitimate therapy and are medically and ethically justifiable. But the potential applications for genetic modification do not stop with prevention and treatment of human disease. Gene-based therapies are one thing, but the intentional modification of the human genome to “improve” individuals, i.e., genetic enhancement, is quite another and beset with different sets of ethical and policy dilemmas. The rapidly developing tools of gene therapy and genome editing are potentially just as pertinent to understanding the mechanisms underlying human development and behavior, cognitive, and intellectual traits as to the formation and function of the human personality. It would probably require no great technical innovation to leap from disease prevention and therapy to attempts to modify and “enhance” human physical and intellectual traits. The temptation to do so is and will continue to be great. The tools of biotechnology, neuroscience, and genetics will increasingly identify many of the mechanisms underlying the development and regulation of human traits, not only of physical properties but also of cognitive, intellectual, and social traits, and make them tempting targets for genetic manipulation. What will be the consequences of modifying and genetically manipulating human functions intended to improve on the “natural”? When will merely “natural” not be good enough? From genetic enhancement to eugenics? Deliberate application of the concept and tools of genetic enhancement of individual human beings and of the human species flows directly into the highly troubling potential for spill-over into programs for design and preferential reproduction of “more desirable” and “better” kinds of human beings – i.e., eugenics. Are we prepared to pursue, accept, and regulate applications of genetic enhancement toward eugenic goals? Humanity has a very fraught relationship with the unsettling concept and the misguided practice of eugenics. The late nineteenth century and the beginning of the twentieth century witnessed the emergence and the flourishing of the concept of eugenics—the attempt to direct human heredity and evolution to ensure procreative advantage to more “desirable” human beings and to discourage or limit reproduction by the less desirables. Such programs relied on efforts to identify and provide advantage to the “favored” and to define methods to disadvantage the “unfavored”. Inspired by concepts born at the Genetics Record Office at Cold Spring Harbor, New York, criteria of social undesirability and social ills came to include the undesirable and purportedly genetic traits of poverty, criminality, mental disorders, laziness and homosexuality, and thalassophilia (love of the sea) among others []. There was obviously little or no truly rigorous scientific evidence of a genetic basis for these presumed genetic components. There were, instead, prejudiced and fact-free presumptions of the causes of social human ills based on imaginary pseudoscience meant to justify restricted immigration of “undesirable” populations to the US mainly from central Europe and Asia. Out of those misguided eugenic concepts emerged racist immigration policies and the disastrous US Supreme Court decision in Buck v. Bell that upheld the legality and ethical justification for implementing involuntary sterilization programs in the United States and other countries that were designed to prevent the birth of human beings identified, no matter how incorrectly, to be deficient and inferior []. This movement, particularly the one in the United States, was a major incubator of even harsher social programs and, in their extreme forms, to the genocidal programs of Nazi Germany. The eugenic landscape in the context of modern science However, the poor scientific bases for these early attempts at eugenics have given way to the proven scientific and manipulative strengths of modern human genetics that make genetic manipulation for the purposes of therapy, enhancement, and even possibly eugenic goals increasingly technically feasible. With time and with scientific advances made over the ensuing many decades, the inadequacy and the folly of such ethically and scientifically indefensible eugenic thinking of the early twentieth century became clear and rightly broadly rejected. Our understanding at that time of the possible long-term multi-generational and population effects of selective manipulations of mechanisms underlying human reproduction and evolution was seriously deficient. Even now, the possible deleterious long-term adverse genetic effects of non-therapeutic genetic enhancement and even “precision” targeted genome editing are not predictable or targeted exquisitely enough to justify their application in non-therapeutic experimental settings. We are justified, and possibly even compelled, by all current codes of ethical principles governing medical practice and biomedical research to use many of these new tools in the name of healing. But if we apply them for whimsical or even well-intentioned genetic enhancement purposes, we should be aware of our inadequate understanding of their potential for long-term and irretrievable harm, and of the likelihood that they can lead us down the path toward unwise eugenic goals. We should heed the warning attributed by some to the great American baseball player and folk philosopher Yogi Berra—“If you don’t know where you’re going, you’ll probably end up someplace else”. At the moment, we do not know where this path of human genetic enhancement and its potential extension to eugenic goals leads. If we wander in that direction, we may wind up in unexpected and societally detrimental and even disastrous places. We should be sure to tread down that road only if and when scientific, ethical, and public policy justifications are more evident than they are now.
2022
SDI
Affirmative
**Human Germline Genetic Engineering** Affirmative › Advantage 1 – Extension › human dignity
Evolution News @DiscoveryCSC January 7, 2022, 1:31 PM Sound the Alarm on Germline Genetic Editing https://evolutionnews.org/2022/01/sound-the-alarm-on-germline-genetic-editing/
Smith argues the health benefits being pursued can be achieved without permanently altering the germlines, and he warns of a brave new world of eugenics pursued using CRISPR technology and germline editing. As he explains, it’s not just that germline editing could lead to unintended health consequences, or that such changes could work their way into the human population in the long term. It’s also that the eugenics mindset driving much of this experimental work threatens to undermine the foundational belief that all humans possess inherent dignity and worth, not just those humans who are genetically edited and enhanced.
2022
SDI
Affirmative
**Human Germline Genetic Engineering** Affirmative › Advantage 1 – Extension › human dignity
Melanie Hess -2020 A Call for an International Governance Framework for Human Germline Gene Editing 95 Notre Dame Law Review 1369 https://scholarship.law.nd.edu/cgi/viewcontent.cgi?article=4899&context=ndlr
The above passage primarily addresses the possibility that the use of germline editing for genetic enhancement would follow if germline editing were to become an acceptable procedure. In terms of acceptability, many distinguish between nontherapeutic genetic enhancement, or gene editing to engineer particular human traits like athleticism or intellect, and therapeutic gene editing, which addresses debilitating or life threatening genetic diseases.61 Marcy Darnovsky, head of the nonprofit Center for Genetics and Society, believes that “[u]nlike curing disease, genetic enhancement would be morally reprehensible.”62 The 1997 film Gattaca provides a cliche, but ´ apt, illustration of the potential societal problems of genetic enhancement and reflects society’s fears about eugenics and genetic interventions. In this dystopian not-too-distant future, parents have the option to conceive children through the genetic selection of the best traits of their parents, and the “in-valids”—individuals who were conceived without genetic intervention— occupy a second-class position in society.63 Despite laws against genetic discrimination, the Gattacan society found ways to relegate inferior employment and social positions to those individuals who were deemed genetically infer ior.64 Even the unrealized potential of such applications demonstrates the necessity of implementing proper regulation before germline editing gets off the ground so that it cannot be abused in these readily imaginable ways. These concerns are related to a commonly invoked principle of the “slippery slope,” in which concessions made to allow “acceptable” applications risk permitting unacceptable applications further down the road.65 There is also the ethical dilemma about the unnaturalness of germline editing and theologically based concerns that germline editing “amounts to playing God.”66 Although allegations of playing God are two a penny in debates about breakthrough technologies, with gene drives they do feel better-founded than usual. The ability to remove species by fiat—in effect, to get them to remove themselves—is, like the prospect of making new species from scratch, a power that goes beyond the past ambit of humankind.67 While the idea of causing extinction or making a species from scratch is referencing nonhuman applications of germline editing, the underlying principle—objecting to the tampering with species, including humankind— remains the same, if not possibly even more objectionable in substance. Even nonreligious persons have moral reservations related to this theory of “playing God” that takes the form of objection to the unnaturalness of the idea and how it constitutes a perceived assault on human dignity. A Pew Research study found that over twenty-five percent of nonreligious people opposed gene editing of a baby, even where doing so would improve that baby’s health, for the exact same reasons as did people who identified as religious—“because it would be meddling with nature and cross a line that should not be crossed.”68 Bioethicists have used the term the “yuck factor” to describe the intuitive aversion people feel when confronted with the idea of genetic engineering. “The Yuck Factor likely has its origins in Kantian and Christian philosophies of human dignity that permeate Western culture . . . [and] emphasize that human life has a higher moral place than the rest of the natural world.”69
2022
SDI
Affirmative
**Human Germline Genetic Engineering** Affirmative › Advantage 1 – Extension › human dignity
Krizia Rivera 2020 Genetic Engineering, Lack of Regulation in the United States of America and its Potentially Problematic Applications
Lulu and Nana are the first genetically modified human on earth. Lulu and Nana did not consent to this treatment. In fact, their entire genetic bloodline who will carry this edited gene in perpetuity has not consented. A grave dishonor has been perpetrated on the personal autonomy and human dignity of the twins and their future progeny. While scientists have predicted potentially harmful effects, 164 they cannot know the unknown. He violated the human rights of not only the twins but of humankind. He opened a door that we can never close. Until a global consensus is formed, the potential for human right violations through germline and somatic genetic engineering remains open.
2022
SDI
Affirmative
**Human Germline Genetic Engineering** Affirmative › Advantage 1 – Extension › human dignity
Roberto Andorno 2022 Human Dignity, Life Sciences Technologies and the Renewed Imperative to Preserve Human Freedom https://www.researchgate.net/profile/Roberto-Andorno/publication/360729946_Human_Dignity_Life_Sciences_Technologies_and_the_Renewed_Imperative_to_Preserve_Human_Freedom/links/628cecf0d4e5243d9b9624f7/Human-Dignity-Life-Sciences-Technologies-and-the-Renewed-Imperative-to-Preserve-Human-Freedom.pdf
A central argument made in this chapter is that the pervasive technology developments that we have been witnessing over the past few decades create new potential threats to human dignity, and therefore resorting to dignity is inescapable to address the new challenges. The need to protect basic human interests in this technological context may require the expansion of existing rights, and maybe even the creation of new rights in order to effectively preserve full respect for intrinsic human dignity. In consonance with this view, Italian legal philosopher Norberto Bobbio argues that the need for a new generation of human rights “arise[s] from the danger posed to life, liberty and security by the growth in technological progress.” 30 As examples of such new rights, he mentions those relating to new threats to privacy and to our genetic integrity. He adds, It does not take much imagination to realize that development of technology, the transformation of social and economic conditions, widening knowledge and the intensification of the means of communication will produce such changes in the organization of human life and social relations as to engender favorable conditions for the creation of new needs and therefore demands for freedoms and powers.31 However, human rights alone are not always sufficient to respond to the emerging challenges posed by technology. Sometimes, a direct recourse to the foundational principle of human dignity seems necessary to stress the utmost importance of the issues at stake. This explains why the instruments relating to bioethics adopted since the 1990s place a much stronger emphasis on the notion of dignity than traditional human rights instruments and even give a broader meaning to this concept. Precisely in those years, and partly as a result of the announcement of the Human Genome Project made in 1990, the notion of human dignity started to be used beyond its classical meaning (i.e., the intrinsic value of every human individual) to articulate disquiet about biotechnological developments that may impact on future generations and on humankind as a whole. Human germline engineering can be regarded as intrinsically problematic as it jeopardizes basic features of the human condition and the common understanding of what it means to be human. It is therefore the dignity of future generations that is at stake here.32
2022
SDI
Affirmative
**Human Germline Genetic Engineering** Affirmative › Advantage 1 – Extension › gene drive
Scott J. Schweikart, Global Regulation of Germline Genome Editing: Ethical Considerations and Application of International Human Rights Law, 43 Loy. L.A. Int'l & Comp. L. Rev. 279 (2021). Available at: https://digitalcommons.lmu.edu/ilr/vol43/iss3/6
Germline genome editing (also sometimes referred to as heritable genome editing) refers “to all manipulations of germline cells,” which include primordial germ cells, gametes, zygotes and embryos.25 CRISPR technology can affect the germline of subsequent generations via a tool called a gene drive.26 A “gene drive actively copies a mutation made by CRISPR on one chromosome to its partner chromosome and thereby ensures that all offspring and subsequent generations will inherit the edited genome.”27 While discussion of gene drives often center around their use in insects (such as mosquitos), they can potentially be used in humans as well.
2022
SDI
Affirmative
**Human Germline Genetic Engineering** Affirmative › Advantage 1 – Extension › autonomy & mosaicism
(Aliya Jane, May 7th 2021, undergraduate student studying Physiological Science, OPINION: CRISPR Technology Violates Informed Consent, May Usher Era of Eugenics, Bruin Medical Review, . Lbok)
Gene editing with CRISPR is used on two different cell types: somatic and germline. Germline cells are reproductive cells that eventually form embryos, sperm and oocytes. When targeting germline cells, effects can be felt for multiple generations due to their ability to pass on genetic information. Somatic cells refer to the rest of the body cells, excluding reproductive cells. Changes in somatic cells will not be passed down generationally. Using CRISPR to edit either type has ethical implications. Off-target mutations in both germline and somatic cells can result in negative health implications. Off-target mutations refer to nonspecific and unintended genetic modifications that can arise through the use of CRISPR. These could lead to very harmful effects on organisms, potentially even resulting in cell death. Germline editing also has a high risk factor because it can alter the genome of future generations. If there is some type of failure while editing the germline, undesirable mutations, side effects and other negative changes can also be inherited. This is especially risky because there is a lack of informed consent for offspring of future generations. Ethical Implications Informed consent is the process in which a health care provider educates a patient about the risks, benefits and alternatives of a given procedure or intervention. The patient, then, makes a voluntary decision about whether to undergo the procedure or intervention. CRISPR violates informed consent. When it is used to edit the germline, the affected unborn fetus cannot give consent to take part in the experimental procedure or manage any complications or undesirable mutations that might arise as a result of the edited germline. Therefore CRISPR violates the fundamental tenet of medicine of providing informed consent.
2022
SDI
Affirmative
**Human Germline Genetic Engineering** Affirmative › Advantage 1 – Extension › autonomy & mosaicism
24 September 2015 Genetically engineering humans: a step too far? https://pharmaceutical-journal.com/article/opinion/genetically-engineering-humans-a-step-too-far
Some scientists have been quick to tout the potential of this new technology as a possible “cure” for some forms of infertility and to prevent various genetic diseases affecting future individuals. These hypothetical techniques would entail editing the genome of human embryos or of stem cells — a practice currently outlawed in the UK — that might then be coaxed into developing into sperm and eggs. What makes such hypothetical uses of genome editing especially controversial is that the genetic modification would — or at least could — affect the germline of the individuals who were brought into existence. Should something go wrong, multiple generations would be at risk. What germline modification could do that existing technologies cannot is produce embryos with particular genes associated with desirable traits. If scientists can find genes that are associated with above-species-typical traits — for example, higher intelligence, longevity, concentration or memory — CRISPR/Cas9 will allow them to insert these genes into embryos. In theory, at least, the CRISPR/Cas9 system would allow parents to insert genes for as many desirable traits as they liked into the genome of their child. Let us not be deluded, then, that the renewed debate about germline genetic engineering, prompted by CRISPR/Cas9, is about rescuing a small number of individuals from the burden of genetic disease. It is nothing less than a debate about what it will mean to be human in the future. Will our grandchildren — or perhaps even children — be born all equally subject to the vicissitudes — and the joys — of the genetic lottery? Or will they be made? Stronger, better perhaps — children of the wealthy more so than others — but are created by designers and so are vulnerable to obsolescence.
2022
SDI
Affirmative
**Human Germline Genetic Engineering** Affirmative › Advantage 1 – Extension › autonomy & mosaicism
Sarah Ruth Bates Rewriting Our Genes Is Easier Than Ever. That Doesn't Mean We Should Do It January 03, 2020 https://www.wbur.org/cognoscenti/2020/01/03/germline-prime-gene-editing-sarah-ruth-bates
That argument pushes us towards a risk we shouldn’t take. “Prime-Editing” is more precise than CRISPR, but that doesn’t make it “safe” for this purpose. If germline gene editing goes wrong, there’s no ethically sound way to stop the resulting domino effect. Gone wrong, germline gene editing has the potential to do widespread damage. Consider the recent that all living human beings descended from one woman who lived in the area we now call Botswana. Scientists have referred to this common ancestor as “Mitochondrial Eve.” Take her as an example — an extreme, but real, example — of the potential reach of one individual’s genes. Editing an embryo’s germline genes means that you’re altering the genetic code of that person, for life — and, if that individual has a baby, they may pass on those altered genes to that baby. If Nana or Lulu have children, they’ll pass on the germline edits Dr. He made — both the intended and the unintended. When they come of age, Nana and Lulu will have to have a version of the “where babies come from?” talk that no human being has ever before experienced, or should have to. The only way to prevent the future transmission of germline edits is to prevent the person whose genes have been edited from reproducing. Nana and Lulu couldn’t have possibly consented to that as a condition of the experiment, because they weren’t alive when the experiment was performed. Limiting their reproductive possibilities in that way would approach eugenics.
Its unethical – too much uncertainty – the complications might not surface for years.
2022
SDI
Affirmative
**Human Germline Genetic Engineering** Affirmative › Advantage 1 – Extension › autonomy & mosaicism
Heggie 18 Heggie, Jon. Jon Heggie is a highly experienced writer with proven success across all media types, offering fast and accurate interpretations of briefs; flexible and perceptive adaptation of style and language; astute revision and editing of supplied copy; thorough research and understanding of subject matter and directly supporting clients, account handlers and creatives. Science, National Geographic, 17 Dec. 2018, . //DRE
Five arguments against germline genome editing Consent A crucial element of any clinical procedure is informed consent—ensuring that the patient fully understands the risks of a treatment. GGE is so new, complex, and uncertain that we cannot adequately inform prospective patients of the risks to them or future generations. This raises the deeper question of whether we have the right to deliberately, permanently, and irrevocably change the human genome without universal consensus. Uncertainty The human genome is an extremely complex ecosystem that we don’t fully understand, so we cannot absolutely predict the impact editing a gene will have. Sometimes multiple genes interact to perform a function, and it’s possible that a single edit could affect many other genes. Nor can we completely guarantee the accuracy of genome editing, so there is always the risk of making unintended changes with unforeseen consequences. Permanence If a change is made in a germline cell, we cannot reverse it. That change will inexorably pass from parent to child through the generations and will spread between families, communities, and countries to become part of humankind forever. As the entire effects of a genetic modification may not become apparent for years, decades, or even generations, permanently altering the human genome is too big a risk to take.
2022
SDI
Affirmative
**Human Germline Genetic Engineering** Affirmative › Advantage 1 – Extension › autonomy & mosaicism
Kaiser 16 Kaiser, Jocelyn. Jocelyn has been a staff writer for Science magazine since 1995. “The Gene Editor CRISPR Won’t Fully Fix Sick People Anytime Soon. Here’s Why.” Science.org, 3 May 2016, www.science.org/content/article/gene-editor-crispr-won-t-fully-fix-sick-people-anytime-soon-here-s-why?cookieSet=1. Accessed 29 June 2022.
And CRISPR still has big safety risks The most-discussed safety risk with CRISPR is that the Cas9 enzyme, which is supposed to slice a specific DNA sequence, will also make cuts in other parts of the genome that could result in mutations that raise cancer risk. Researchers are moving quickly to make CRISPR more specific. For example, in January, one lab described a tweak to Cas9 that dramatically reduces off-target effects. And in April in Nature, another team showed how to make the enzyme more efficient at swapping out single DNA bases. But immediate off-target cuts aren't the only worry. Although it's possible to deliver CRISPR's components into cells in a dish as proteins or RNA, so far researchers can usually only get it working in tissue inside the body by using a viral vector to deliver the DNA for Cas9 into cells. This means that even after Cas9 has made the desired cuts, cells will keep cranking it out. "The enzyme will still hang around over 10, 20 years," Zhang says. That raises the chances that even a very specific Cas9 will still make off-target cuts and that the body will mount an immune response to the enzyme. This may not truly be a problem, Zhang suggests. His team created a mouse strain that is born with the gene for Cas9 turned on all the time, so it expresses the enzyme in all cells for the animal's entire life. Even after interbreeding these mice for about 20 generations, the mice "seem to be fine" with no obvious abnormal health effects, Zhang says. All the same, "the most ideal case is, we want to shut off the enzyme." And that may mean finding nonviral methods for getting Cas9 into cells, such as ferrying the protein with lipids or nanoparticles—delivery methods that biologists have long struggled to make work in living animals. Other long-standing obstacles to gene therapy will confront efforts using CRISPR, too. Depending on the disease, any gene-edited cells may eventually die and patients could have to be treated multiple times. Researchers using gene transfer and editing approaches are also both hindered by limits on how much DNA a viral vector can carry. Right now CRISPR researchers often must use two different viruses to get CRISPR's components into cells, which is less efficient than a single vector.
2022
SDI
Affirmative
**Human Germline Genetic Engineering** Affirmative › Advantage 1 – Extension › autonomy & mosaicism
Ledford 20 Ledford, Heidi. Heidi Ledford, Senior Reporter, London Heidi writes about biology and medicine, and has a PhD from the University of California, Berkeley. Heidi has written for The Oregonian, edited for the Berkeley Science Review, and freelanced for a few other publications. ““CRISPR Babies” Are Still Too Risky, Says Influential Panel.” Nature, 3 Sept. 2020, www.nature.com/articles/d41586-020-02538-4, 10.1038/d41586-020-02538-4. Accessed 28 June 2022. //DRE
Editing genes in human embryos could one day prevent some serious genetic disorders from being passed down from parents to their children — but, for now, the technique is too risky to be used in embryos destined for implantation, according to a high-profile international commission. And even when the technology is mature, its use should initially be permitted in only a narrow set of circumstances, the panel says. The recommendations, released in a report on 3 September, were produced by experts in ten countries convened by the US National Academy of Medicine, the US National Academy of Sciences and the UK Royal Society. The document joins a wealth of reports compiled in recent years that have argued against using gene editing in the clinic until researchers are able to address safety worries, and the public has had a chance to comment on ethical and societal concerns. “The technology is not presently ready for clinical application,” says Richard Lifton, president of the Rockefeller University in New York City and co-chair of the commission. The report — which reviewed the scientific and technical state of heritable gene editing, rather than ethical questions — advocates the formation of an international committee to evaluate developments in the technology and advise national advisory groups and regulators on its safety and utility. The commission was formed after Chinese biophysicist He Jiankui shocked the world in 2018 by announcing that he had edited human embryos that were then implanted, in an effort to make the resulting children resistant to HIV infection. The work, which was widely condemned by scientists and yielded prison sentences for He and two of his colleagues, led to the birth of two children with edited genomes. Unwanted changes Although genome-editing technologies such as CRISPR–Cas9 offer a fairly precise way to edit the genome, they have been shown to generate some unwanted changes to genes, and can produce a range of different outcomes even among cells in the same embryo. It could be years before researchers are able to iron out these difficulties, says Haoyi Wang, a developmental biologist at the Chinese Academy of Sciences’ Institute of Zoology in Beijing, and a commission member. In addition, Wang says, scientists need to develop better methods for thoroughly sequencing a human genome from single cells, so that an edited embryo can be screened in detail for unwanted genetic changes. The report also recommends that if, after thorough discussion with the public, individual nations decide that they are ready to move forwards with heritable genome editing, the practice should initially be limited to serious genetic disorders that are caused by DNA variants in a single gene. Even then, it should be used only when the alternatives for having a biologically related child that is unaffected by the genetic disorder are poor. “The report lays out very, very well just how rare it’s going to be that people actually need to access heritable human-genome editing,” says Jackie Leach Scully, a bioethicist at the University of New South Wales in Sydney, Australia. For example, in some cases people will instead be able to screen out embryos that carry a disease-causing genetic mutation. “We understand that not many couples would fall into these categories,” says Kay Davies, a geneticist at the University of Oxford, UK, and co-chair of the commission. “There would be a need for international cooperation in doing these first cases because there would be so few worldwide.”
2022
SDI
Affirmative
**Human Germline Genetic Engineering** Affirmative › Advantage 1 – Extension › autonomy & mosaicism
Melanie Hess -2020 A Call for an International Governance Framework for Human Germline Gene Editing 95 Notre Dame Law Review 1369 https://scholarship.law.nd.edu/cgi/viewcontent.cgi?article=4899&context=ndlr
Legal professor and bioethicist Katherine Drabiak describes the rhetoric around gene editing “intentionally misleading,” stating that the current state of technology is not as efficient as it is believed to be in terms of its potential benefits, and that, in fact, there is significant risk involved.47 The medical risks associated with germline gene editing include mosaicism, meaning some genes contain the intended modification and others do not. This can lead to serious health risks in later stages of development48 and other off target effects. Off-target effects “refer to a range of unintended outcomes” that can have serious health impacts on the child, including advanced aging or the development of tumors.49 Problematically, preimplantation genetic diagnosis (PGD), a process used to test the health of an embryo prior to implantation for pregnancy,50 often fails to accurately assess the effects of gene editing on an embryo. The inability to use PGD to test the health of an edited embryo would make it difficult to ascertain the germline editing procedure’s effectiveness prior to the embryo’s implantation. In other words, PGD cannot be used as a safeguard to indicate whether the editing has worked correctly prior to implantation.51 PGD can, however, be used to assess whether a defective gene is present in an unedited embryo, which is why Drabiak points to this as a better alternative to germline editing.52 Finally, there are a range of unpredictable effects that may emerge at any point in the future person’s life as a result of tampering with their initial germline cells. Drabiak notes that current research touting effectiveness incorrectly presumes that, following a gene editing procedure, “embryo survival equates to health.”53 In other words, a test subject embryo’s surviving the trial is not necessarily an indication of how the fetus will fare in the next nine months, or the years and decades following its birth. Some scholars believe that “germline modification will never be safe . . . because interactions between genes are highly integrated, designed to achieve stability and balance, and manipulation of one location risks disrupting the biological equilibrium.”54 Of course, this poses a serious obstacle to any research: with the current expert consensus on a moratorium on any applications that would result in a pregnancy,55 it is not possible to observe effects of germline editing on later stages of development of a child. Drabiak proposes that these risks are severe enough that they easily outweigh any benefits that germline gene editing could ever theoretically provide.56
2022
SDI
Affirmative
**Human Germline Genetic Engineering** Affirmative › 1AC
Melanie Hess -2020 A Call for an International Governance Framework for Human Germline Gene Editing 95 Notre Dame Law Review 1369 https://scholarship.law.nd.edu/cgi/viewcontent.cgi?article=4899&context=ndlr
For a combination of all of these reasons, experts across fields with knowledge on the subject of gene editing, and particularly germline editing, are calling for caution. The aforementioned CRISPR pioneer Feng Zhang of the Broad Institute of Harvard and MIT, in supporting a moratorium, noted that before beginning experimentation, society needs to decide if human germline editing is even a good that should be pursued. If that is decided, he said, “we need to have guidelines first so that the people who do this work can proceed in a responsible way, with the right oversight and quality controls.”71 In reaction to Dr. He’s revelation at the 2018 summit, David Baltimore, chair of the Summit Organizing Committee, called the fact of the experiment “a failure of self-regulation by the scientific community.”72 Furthermore, following both the 2015 and 2018 summits, groups of scientists and experts put out calls for a moratorium on clinical applications of human germline editing until a “broad societal consensus” could be reached and an international governance framework established.73 While this consensus has not been reached and may in fact be far away,74 presumably there should be a governance framework ready to govern applications prior to this consensus to ensure that society and science proceed with caution, wisdom, and oversight. Furthermore, the development of principles and potential regulatory regimes may in fact help different arms of society come together in dialogue about the issue; in other words, resolving governance issues on the topic may be an important step in achieving this consensus.
2022
SDI
Affirmative
**Human Germline Genetic Engineering** Affirmative › 1AC
Kelley M. Sayler April 6, 2022 Emerging Military Technologies: Background and Issues for Congress Updated April 6, 2022 https://sgp.fas.org/crs/natsec/R46458.pdf
Congress has expressed an interest in conducting oversight of the military applications of emerging biotechnologies. For example, per Section 263 of the FY2020 NDAA (P.L. 116-92), DOD is to conduct “a review of the military understanding and relevancy of applications of emerging biotechnologies to national security requirements of the Department of Defense” and provide recommendations for future legislative and administrative activities.” 132 Section 278 of the FY2021 NDAA (P.L. 116-283) directs DOD to “conduct an assessment and direct comparison of capabilities in emerging biotechnologies for national security purposes ... between the capabilities of the United States and the capabilities of adversaries of the United States.” 133 Finally, Section 1091 of the FY2022 NDAA (P.L. 117-81) establishes the National Security Commission on Emerging Biotechnology, which is to “consider the methods, means, and investments necessary to advance and secure the development of biotechnology, biomanufacturing, and associated technologies by the United States to comprehensively address the national security and defense needs of the United States.” The commission is to deliver its interim findings and recommendations to the congressional defense committees and the President no later than January 26, 2023, and its final report no later than January 26, 2024.134
2022
SDI
Affirmative
**Human Germline Genetic Engineering** Affirmative › 1AC
Lander, et.al. 2019 Eric S. Lander , Françoise Baylis , Feng Zhang , Emmanuelle Charpentier , Paul Berg , Catherine Bourgain , Bärbel Friedrich , J. Keith Joung , Jinsong Li , David Liu , Luigi Naldini , Jing-Bao Nie , Renzong Qiu , Bettina Schoene-Seifert , Feng Shao , Sharon Terry , Wensheng Wei & Ernst-Ludwig Winnacker 13 March 2019 Adopt a moratorium on heritable genome editing https://www.nature.com/articles/d41586-019-00726-5
Some argue, especially in the popular press, that germline editing is urgently needed to stop children from being born with severe genetic diseases. But couples who know they are at risk of transmitting a severe disease-causing mutation already have safe ways to avoid doing so. They can use in vitro fertilization (IVF) in conjunction with preimplantation genetic testing (PGT), prenatal testing, sperm donors, egg donors, embryo donors or adoption. In particular, use of IVF followed by genetic screening of the embryos to ensure that only unaffected ones are transferred to the person’s uterus, guarantees that a couple will not have children with the genetic disease. The real problem is that most children with severe genetic diseases are born to couples who did not know they were at risk. Routine access to preconception genetic screening could allow most at-risk couples to make use of current options, should they wish to do so. Better access to newborn screening is also needed, to ensure that babies with a genetic disease can immediately receive any available therapy.
2022
SDI
Affirmative
**Human Germline Genetic Engineering** Affirmative › 1AC
WESLEY W. CHEN June 30 2019 HUMAN GERMLINE GENE EDITING: ENGINEERING AN UNSTOPPABLE TRAIN https://mylaw2.usc.edu/why/students/orgs/ilj/assets/docs/28-2-Chen.pdf
Regardless of the potential impact of gene editing on diversity or inequality, society is not yet equipped with the technology to safely edit human germlines. Since 2003 and the completion of Human Genome Project, we have fully mapped the DNA of human beings.132 However, the knowledge of a human’s nucleotide sequence is a far cry from knowing how genes interact within one another and affect the human physiology. If germline gene modification is likely to have significant medical benefits, is it nevertheless justified if there are still unknown chances that it could have other unintended, adverse consequences as well? Perhaps with some fatal diseases, such as Huntington’s Disease, where a single point mutation causes all symptoms, the benefits of the potential cure may outweigh the safety risks of germline gene editing. In fact, just this year, the U.S. National Academy of Science and the National Academy of Medicine released a report suggesting that such gene editing clinical trials “‘might be permitted, but only following much more research’ on the risks and benefits, and ‘only for compelling reasons and under strict oversight.’” 133 Although clinical germline gene editing may be technologically possible in the near future, the state of current gene editing technology does not yet justify the start of clinical applications. The potential benefits of germline gene editing notwithstanding, society has a responsibility to consider the best interests of the potential human life if gene editing still poses significant adverse risks. Currently, there are still too many issues with off-target gene editing (undesired typos in gene editing) and too many questions regarding what unforeseen consequences gene editing may have on future generations.134 Gene editing technology and our understanding of genetics will develop in time, but until we can definitively engineer an embryo without significant detrimental effects, there will remain significant questions surrounding medical applications of germline gene editing. Therefore, it is imperative that we support basic science research in human embryos if clinical gene editing treatments are ever to see the light of day.